Clinical impact of pregnancy in mastocytosis: A study of the Spanish network on mastocytosis (REMA) in 45 cases

International Archives of Allergy and Immunology

Volumn 156, Issue 1, 2011, Pages 104-111

  Matito, A ^a,c   Alvarez Twose I ^a,c   Morgado, J M ^a,c   Sanchez Munoz L ^a,c   Orfao, A ^b,c   Escribano, L ^a,c  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c Red Española de Mastocitosis REMA   (Spain)

Author keywords

Anaphylaxis; Mast cell related symptoms; Mastocytosis; Pregnancy

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DELIVERY; DISEASE COURSE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MAST CELL; MASTOCYTOSIS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUERPERIUM; SKIN DEFECT; SPAIN; STRUCTURED QUESTIONNAIRE; THIRD TRIMESTER PREGNANCY;

ADULT; FEMALE; HUMANS; INFANT, NEWBORN; MAST CELLS; MASTOCYTOSIS; MASTOCYTOSIS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SPAIN;

EID: 84860423228     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000321954     Document Type: Article

References (45)

1. Fukuoka Y, Xia HZ, Sanchez-Munoz LB, Dellinger AL, Escribano L, Schwartz LB: Generation of anaphylatoxins by human beta- tryptase from C3, C4, and C5. J Immunol 2008; 180: 6307-6316.
2. Galli SJ, Dvorak AM, Dvorak HF: Basophils and mast cells: Morphologic insights into their biology, secretory patterns, and function. Prog Allergy 1984; 34: 1-141.
3. Metzger H: The high affinity receptor for IgE on mast cells. Clin Exp Allergy 1991; 21: 269-279.
4. Núñez-López R, Escribano L, Schemthaner GH, Prados A, Rodríguez-González R, Díaz- Agustín B, López A, Hauswirth A, Valent P, Almeida J, Bravo P, Orfao A: Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol 2003; 120: 257-265.
5. Valent P, Bettelheim P: Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Adv Immunol 1992; 52: 333-423.
6. Lobell RB, Austen KF, Katz HR: FcgammaRmediated endocytosis and expression of cell surface FcgammaRIIb1 and FcgammaRIIb2 by mouse bone marrow culture- derived progenitor mast cells. J Immunol 1994; 152: 811-818.
7. el Lati SG, Dahinden CA, Church MK: Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 1994; 102: 803-806.
8. Mousli M, Hugli TE, Landry Y, Bronner C: Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology 1994; 27: 1-11.
9. Kim MS, Chae HJ, Shin TY, Kim HM, Kim HR: Estrogen regulates cytokine release in human mast cells. Immunopharmacol Immunotoxicol 2001; 23: 495-504.
10. Jeziorska M, Salamonsen LA, Woolley DE: Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod 1995; 53: 312-320.
11. Garfield RE, Irani AM, Schwartz LB, Bytautiene E, Romero R: Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus. Am J Obstet Gynecol 2006; 194: 261-267.
12. Garfield RE, Bytautiene E, Vedernikov YP, Marshall JS, Romero R: Modulation of rat uterine contractility by mast cells and their mediators. Am J Obstet Gynecol 2000; 183: 118-125.
13. Padilla L, Reinicke K, Montesino H, Villena F, Asencio H, Cruz M, Rudolph MI: Histamine content and mast cells distribution in mouse uterus: The effect of sexual hormones, gestation and labor. Cell Mol Biol 1990; 36: 93-100.
14. Rudolph MI, Reinicke K, Cruz MA, Gallardo V, Gonzalez C, Bardisa L: Distribution of mast cells and the effect of their mediators on contractility in human myometrium. Br J Obstet Gynaecol 1993; 100: 1125-1130.
15. Mullins RJ, Russell A, McGrath GJ, Smith R, Sutherland DC: Breastfeeding anaphylaxis. Lancet 1991; 338: 1279-1280.
16. Shank JJ, Olney SC, Lin FL, McNamara MF: Recurrent postpartum anaphylaxis with breast-feeding. Obstet Gynecol 2009; 114: 415-416.
17. Worobec AS, Akin C, Scott LM, Metcalfe DD: Mastocytosis complicating pregnancy. Obstet Gynecol 2000; 95: 391-395.
18. Donahue JG, Lupton JB, Golichowski AM: Cutaneous mastocytosis complicating pregnancy. Obstet Gynecol 1995; 85:813-815.
19. Garcia Collada JC, Pereda Marin RM, Miralles SE, Pacheco Lopez JF: Epidural analgesia for labor in a patient with systemic mastocytosis. Rev Esp Anestesiol Reanim 2000; 47: 326-327.
20. Kehoe SL, Bathgate SL, Macri CJ: Use of a doula for labor coaching in a patient with indolent systemic mastocytosis in pregnancy. Obstet Gynecol 2006; 107: 514-516.
21. Notter A, Colomb D, Cosentino JL, Latarche M, Virieux C: Mastocytosis and pregnancy: A case of urticaria pigmentosa. Bull Fed Soc Gynecol Obstet Lang Fr 1969; 21: 455-456.
22. Villeneuve V, Kaufman I, Weeks S, Deschamps A: Anesthetic management of a labouring parturient with urticaria pigmentosa. Can J Anaesth 2006; 53: 380-384.
23. Horny HP, Metcalfe DD, Bennet JM, Bain BJ, Akin C, Escribano L, Valent P: Mastocytosis; in Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, ed 4. Lyon, IARC, 2008, pp 54-63.
24. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD: A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004; 103: 3222-3225.
25. Serrano Villar S, Perez-Somarriba J, Sainz Costa T, Winstanley S, Santillana Lopez T, Escribano Mora L, Orejas Gonzalez B: A 38 year old woman with hypotensive shock at the onset of menstruation: Case progression. BMJ 2009; 338:b247
26. Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, Brooks EG, Watson CS, Goldblum RM, Midoro-Horluti T: Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 2007; 44: 1977-1985.
27. Vasiadi M, Kempuraj D, Boucher W, Kalogeromitros D, Theoharides TC: Progesterone inhibits mast cell secretion. Int J Immunopathol Pharmacol 2006; 19: 787-794.
28. Duffy SM, Lawley WJ, Kaur D, Yang WD, Bradding P: Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation. J Allergy Clin Immunol 2003; 112: 965-972.
29. Greenblatt EP, Chen L: Urticaria pigmentosa: An anesthetic challenge. J Clin Anesth 1990; 2: 108-115.
30. Vaughan ST, Jones GN: Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia 1998; 53: 804-807.
31. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC: Incidence of early loss of pregnancy. N Engl J Med 988; 319: 189-194.
32. Martinez-Frias ML, Bermejo E, Rodriguez- Pinilla E, Dequino G: Secular evolution and evolution according to autonomous communities of the frequency of fertility treatments, multiple deliveries and cesarean sections in Spain. Med Clin (Barc) 2005; 124: 132-139.
33. Río I, Castelló A, Jané M, Prats R, Barona C, Más R, Rebagliato M, Zurriaga O, Bolúmar F: Reproductive and perinatal health indicators in immigrant and Spanish born women in Catalonia and Valencia (2005-2006) (in Spanish). Gac Sanit 2010; 24: 123-127.
34. Ronda E, Hernandez-Mora A, Garcia AM, Regidor E: Maternal occupation, pregnancy length and low birth weight. Gac Sanit 2009; 23: 179-185.
35. Anstey A, Lowe DG, Kirby JD, Horton MA: Familial mastocytosis: A clinical, immunophenotypic, light and electron microscopic study. Br J Dermatol 1991; 125: 583-587.
36. Clark DP, Buescher L, Havey A: Familial urticaria pigmentosa. Arch Intern Med 1990; 150: 1742-1744.
37. Escudero OJ, Menacho Fuentes MR, Moreno Gimenez JC, Camacho MF: Diffuse cutaneous mastocytosis: Apropos of 2 familial cases (in Spanish). Med Cutan Ibero Lat Am 1987; 15: 71-74.
38. Fowler JF Jr, Parsley WM, Cotter PG: Familial urticaria pigmentosa. Arch Dermatol 1986; 122: 80-81.
39. James MP, Eady RA: Familial urticaria pigmentosa with giant mast cell granules: A clinical, light, and electron microscopic study. Arch Dermatol 1981; 117: 713-718.
40. Tang X, Boxer M, Drummond A, Ogston P, Hodgins M, Burden AD: A germline mutation in KIT in familial diffuse cutaneous mastocytosis. J Med Genet 2004; 41: 89-93.
41. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A, Aldanondo I, Sanchez L, Dominguez M, Botana LM, Sanchez-Jimenez F, Sotlar K, Almeida J, Escribano L, Orfao A: KIT mutation in mast cells and other bone marrow haematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366-2372.
42. Teodosio C, Garcia-Montero AC, Jara-Acevedo M, Sánchez-Muñoz L, Alvarez-Twose I, Núñez R, Schwartz LB, Walls AF, Escribano L, Orfao A: Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 2010; 125: 719-726.
43. Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, Hadj-Rabia S, Nasca L, Georgin-Lavialle S, Cohen-Akenine A, Launay JM, Barete S, Feger F, Arock M, Catteau B, Sans B, Stalder JF, Skowron F, Thomas L, Lorette G, Plantin P, Bordigoni P, Lortholary O, de Prost Y, Moussy A, Sobol H, Dubreuil P: Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010; 130: 804-815.
44. Longley BJ Jr, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ, Heitjan D, Ma Y: Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999; 96: 1609-1614.
45. Chen W, Mempel M, Schober W, Behrendt H, Ring J: Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008; 63: 1418-1427